Home
>
National Drug Code (NDC)
>
Methotrexate Sodium
Methotrexate Sodium - 66758-041-01 - (Methotrexate Sodium)
Drug Information of Methotrexate Sodium
| Product NDC: | 66758-041 |
| Proprietary Name: | Methotrexate Sodium |
| Non Proprietary Name: | Methotrexate Sodium |
| Active Ingredient(s): | 25 mg/mL & nbsp; Methotrexate Sodium |
| Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate Sodium
| Product NDC: | 66758-041 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090029 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090601 |
Package Information of Methotrexate Sodium
| Package NDC: | 66758-041-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (66758-041-01) > 40 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Methotrexate Sodium
| NDC Code | 66758-041-01 |
| Proprietary Name | Methotrexate Sodium |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (66758-041-01) > 40 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 66758-041 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methotrexate Sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Start Marketing Date | 20090601 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
